ID: ALA302007

Max Phase: Preclinical

Molecular Formula: C17H15ClN2O

Molecular Weight: 298.77

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC1(Cc2ccc(Cl)cc2)c2ccccc2C2=NCCN21

Standard InChI:  InChI=1S/C17H15ClN2O/c18-13-7-5-12(6-8-13)11-17(21)15-4-2-1-3-14(15)16-19-9-10-20(16)17/h1-8,21H,9-11H2

Standard InChI Key:  FNLMEDGQBVFDCQ-UHFFFAOYSA-N

Associated Targets(Human)

NFKB2 Tchem Nuclear factor NF-kappa-B complex (2307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania braziliensis (1091 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania amazonensis (3813 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Leishmania donovani (89745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ferriprotoporphyrin IX (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1d Alpha-1d adrenergic receptor (1475 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1a Alpha-1a adrenergic receptor (3346 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Adra1b Alpha-1b adrenergic receptor (2470 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Human immunodeficiency virus (3636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
tat Human immunodeficiency virus type 1 Tat protein (75 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CV-1 (316 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium berghei (192651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 298.77Molecular Weight (Monoisotopic): 298.0873AlogP: 2.80#Rotatable Bonds: 2
Polar Surface Area: 35.83Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.20CX Basic pKa: 4.49CX LogP: 3.50CX LogD: 3.49
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.93Np Likeness Score: -0.12

References

1. del Olmo E, Armas MG, López-Pérez JL, Muñoz V, Deharo E, San Feliciano A..  (2001)  Leishmanicidal activity of some stilbenoids and related heterocyclic compounds.,  11  (16): [PMID:11514152] [10.1016/s0960-894x(01)00387-0]
2. del Olmo E, Armas MG, López-Pérez JL, Ruiz G, Vargas F, Giménez A, Deharo E, San Feliciano A..  (2001)  Anti-Trypanosoma activity of some natural stilbenoids and synthetic related heterocyclic compounds.,  11  (20): [PMID:11591517] [10.1016/s0960-894x(01)00562-5]
3. del Olmo E, Armas MG, Ybarra M, López JL, Oporto P, Giménez A, Deharo E, San Feliciano A..  (2003)  The imidazo[2,1-a]isoindole system. A new skeletal basis for antiplasmodial compounds.,  13  (16): [PMID:12873511] [10.1016/s0960-894x(03)00509-2]
4. del Olmo E, Barboza B, Ybarra MI, López-Pérez JL, Carrón R, Sevilla MA, Boselli C, San Feliciano A..  (2006)  Vasorelaxant activity of phthalazinones and related compounds.,  16  (10): [PMID:16513345] [10.1016/j.bmcl.2006.02.003]
5. Bedoya LM, del Olmo E, Sancho R, Barboza B, Beltrán M, García-Cadenas AE, Sánchez-Palomino S, López-Pérez JL, Muñoz E, San Feliciano A, Alcamí J..  (2006)  Anti-HIV activity of stilbene-related heterocyclic compounds.,  16  (15): [PMID:16713260] [10.1016/j.bmcl.2006.04.087]
6. Zamilpa A, Herrera-Ruiz M, Del Olmo E, López-Pérez JL, Tortoriello J, San Feliciano A..  (2007)  [1,3]Diazaheterofused isoindolol derivatives displaying anxiolytic-like effects on mice.,  17  (14): [PMID:17507222] [10.1016/j.bmcl.2007.04.080]
7. del Olmo E, Barboza B, Chiaradia LD, Moreno A, Carrero-Lérida J, González-Pacanowska D, Muñoz V, López-Pérez JL, Giménez A, Benito A, Martínez AR, Ruiz-Pérez LM, San Feliciano A..  (2011)  Antimalarial activity of imidazo[2,1-a]isoindol-5-ol derivatives and related compounds.,  46  (11): [PMID:21940072] [10.1016/j.ejmech.2011.08.043]
8. Arsène S, Gómez-Pérez V, Escarcena R, Abengózar MÁ, García-Hernández R, Nácher-Vázquez M, San Feliciano A, Gamarro F, Rivas L, Olmo ED..  (2019)  Imidazo[2,1-a]isoindole scaffold as an uncharted structure active on Leishmania donovani.,  182  [PMID:31419778] [10.1016/j.ejmech.2019.111568]

Source